{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-200433","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2022-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.312330+00:00","generated_at":"2026-06-24T09:18:01.850892+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Ginkgo to acquire Zymergen for ~$300M all-stock; Zymergen holders get 0.9179 DNA shares","bullets":["Deal valued at ~$300M market cap; fixed exchange ratio of 0.9179 Ginkgo shares per Zymergen share.","Zymergen stockholders will own 5.25% of pro forma combined company after transaction close.","Voting agreements from holders of ~40% of Zymergen shares to vote in favor of the merger.","Integration expected to accelerate Ginkgo's platform; Zymergen to evaluate strategic alternatives for Advanced Materials and Drug Discovery.","Transaction subject to regulatory approvals, Zymergen stockholder vote, and other conditions; expected close by Jan 24, 2023 with extension options."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-200433","json":"https://secwatch.observer/filing/0001193125-22-200433.json","markdown":"https://secwatch.observer/filing/0001193125-22-200433.md","text":"https://secwatch.observer/filing/0001193125-22-200433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000119312522200433/0001193125-22-200433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000119312522200433/d368627d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:18:01.850892+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}